Western blot analysis of tumor tissue revealed that tumors harvested from mice with relapse, as well as tumors from all other treatment groups, were still positive for uPARAP at the point of sacrifice (Supplementary Figure 1). This evidence concerns the gene MRC2 and neoplasm.